Blossom Genetics named in top ten most promising European cannatech startups

Cannatech start-up, Blossom Genetics has been named as one of the most promising cannabis start-ups in a review by the publication EU-Startups.
The editor has chosen 10 European-born startups founded in the past few years that are changing the cannabis landscape of Europe; with innovative products ranging from stress-relief chewing gum, to CBD-infused tampons for pain relief.
In recent years, Europe has been witnessing a shift regarding the legalization, cultivation, and trade of medical cannabis, creating a new opportunity for startups and entrepreneurs.
Blossom Genetics, founded in 2019 by Oliver Davies, Oskar Fletcher and Naeem Dungarwalla, aims to utilising their experience of growing and breeding soft fruit to develop medical grade cannabis genetics and products.
The current cannatech portfolio consists of two different products: cannabis genetics and medical cannabis (whole cannabis flower). The London-based startup raised an initial pre-seed funding round led by Deepbridge Capital in April 2020 to accelerate the journey.